CRM Inked Collaboration with NCC Japan for Cancer Research

CRM signed an MoU with National Cancer Center Hospital Japan earlier today, witnessed by Health DDG (Research & Technical Support), Dr Hishamshah. The partnership with Japan’s top oncology hospital paves the way to progressive oncology drug development in the country and region.

Asone of thepartners in Asia forthe ATLAS (Asian clinicalTriaLsnetwork forcAncerS) projectestablished bytheNational CancerCenterJapan (NCCJ), Malaysiawillbenefitfrom early phase oncology drug development, cancer genomic medicineadvancementanddrug access and development.

The MoU with NCCHspells out collaboration in the areas of cancer researchthat includes infrastructuredevelopment, training opportunities in clinical research, participation in rare cancerclinical trial,networking opportunitiesas well asvisits/attachmentsbyresearch expertsfrom both countries.

Comments